CDKN2B rs13333226: Understanding Your Genetic Risk Profile
The rs13333226 variant is a well-studied genetic marker located near the CDKN2B gene. It is widely recognized in scientific literature as a risk factor associated with an increased susceptibility to coronary artery disease.
What each genotype means
Baseline risk profile
This genotype represents the baseline state for this variant in the CDKN2B region. Research indicates that individuals without the risk-associated allele do not carry the increased statistical association for coronary artery disease linked to this specific genetic marker.
This genotype is common in most global populations, though exact frequencies vary by ancestry.
Increased risk profile
Carrying one copy of the risk-associated allele is statistically linked to a moderately higher risk of developing coronary artery disease. This association is well-established in large-scale genomic studies, though it is only one of many factors that influence cardiovascular health.
This heterozygous genotype is frequently observed across diverse populations worldwide.
Elevated risk profile
Carrying two copies of the risk-associated allele is associated with a higher statistical predisposition to coronary artery disease compared to those with the baseline genotype. While this variant is a recognized risk factor, it does not guarantee the development of disease, as cardiovascular health is influenced by a complex interplay of genetics, lifestyle, and environment.
This genotype is common in many populations, with prevalence rates that are well-documented in large-scale biobank studies.
What is the rs13333226 Variant?
The rs13333226 variant is a single-nucleotide polymorphism, or SNP, which is a variation at a single position in the DNA sequence. This specific SNP is located on chromosome 9 in a region that is highly significant for cardiovascular health. In the context of human genetics, SNPs are the most common type of genetic variation, and they often serve as signposts that help researchers identify regions of the genome that may influence health outcomes. Because rs13333226 is situated in a non-coding region near the CDKN2B gene, it is thought to play a role in regulating how nearby genes are expressed rather than changing the structure of a protein directly. Scientists use these markers to study the complex, polygenic nature of heart disease, where many small genetic contributions combine with lifestyle and environmental factors to influence an individual's overall risk profile.
The Role of the CDKN2B Gene
The CDKN2B gene provides instructions for making a protein that acts as a tumor suppressor, helping to regulate the cell cycle and prevent cells from dividing too rapidly. While its primary function is often discussed in the context of cell growth and cancer research, its location on chromosome 9 is also a hotspot for cardiovascular research. The region containing CDKN2B and its neighbor, CDKN2A, is frequently implicated in genome-wide association studies (GWAS) related to heart health. Researchers believe that variations in this genomic neighborhood may influence the behavior of vascular smooth muscle cells or other tissues involved in the development of atherosclerosis. By studying how this gene and its surrounding regulatory elements function, scientists hope to better understand the biological pathways that lead to the narrowing of arteries, which is the hallmark of coronary artery disease.
Evidence and Statistical Associations
The association between rs13333226 and coronary artery disease is supported by extensive research, including large-scale genome-wide association studies involving hundreds of thousands of participants. These studies consistently identify this locus as a significant contributor to genetic susceptibility for cardiovascular conditions. It is important to understand that this is a statistical association, not a deterministic one. Having this variant does not mean an individual will develop heart disease, nor does its absence guarantee protection. Instead, the variant is one of many genetic factors that contribute to an individual's overall risk. The evidence strength is considered moderate because, while the statistical link is robust across many populations, the exact biological mechanism—how the variant leads to disease—remains a subject of ongoing investigation. Genetic risk is only one piece of a much larger puzzle that includes diet, exercise, smoking status, and blood pressure.
Population Frequency and Distribution
The rs13333226 variant is common across most global populations, meaning that a significant portion of the human population carries at least one copy of the risk-associated allele. Because it is a common variant, it is frequently included in genetic panels and research studies. Its prevalence varies slightly by ancestry, but it is widely distributed, which allows researchers to study its effects across diverse groups. Understanding the frequency of this variant helps scientists refine their models of genetic risk, ensuring that findings are applicable to a broad range of people. While the variant is common, the degree to which it influences disease risk can still vary depending on the genetic background and environmental context of the individual. This widespread presence underscores the importance of viewing genetic information as a tool for understanding population-level trends rather than as a definitive diagnostic indicator for any single person.
What You Can Do With This Information
Learning about your genetic variants can be an educational experience, but it is essential to approach this information with the right perspective. Genetic data regarding coronary artery disease risk is intended to provide insight into your biological predispositions, not to serve as a medical diagnosis. If you have concerns about your heart health, the most effective steps you can take involve focusing on modifiable lifestyle factors, such as maintaining a heart-healthy diet, engaging in regular physical activity, and managing stress. You should never use genetic information to make decisions about medications or to alter your current treatment plan without consulting a qualified healthcare professional. Always discuss your genetic results with your doctor or a genetic counselor, who can help you interpret the findings in the context of your personal and family medical history. They are the best resources for determining if further clinical screening or preventative measures are appropriate for you.
How common is this variant?
The rs13333226 variant is common in most global populations, with the specific allele frequencies varying by ancestry.
Frequently asked questions
Does having the rs13333226 variant mean I will get heart disease?
No, having this variant does not mean you will develop heart disease. It is a statistical risk factor, meaning it is associated with a slightly higher likelihood of the condition, but it is not a direct cause.
Can I change my genetic risk for coronary artery disease?
You cannot change your DNA, but you can significantly influence your overall risk through lifestyle choices. Factors like diet, exercise, and not smoking play a major role in heart health regardless of your genetic profile.
Should I take medication if I have this variant?
You should never start, stop, or change any medication based on genetic test results without consulting your doctor. Always discuss your health concerns and genetic findings with a qualified healthcare provider.
Where can I find more information about this SNP?
You can explore resources like the GWAS Catalog, ClinVar, and MedlinePlus Genetics for detailed, peer-reviewed information. These databases provide curated data on genetic variants and their associations with human traits.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs13333226?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2B
This variant is located in the CDKN2B-AS1 region and is a well-established risk factor for primary open-angle glaucoma and associated optic disc traits.
This SNP is a well-replicated marker for cardiovascular disease risk and myocardial infarction susceptibility.
This variant is associated with increased risk for coronary artery disease and related cardiovascular conditions.
This SNP has been identified as a susceptibility marker for meningioma risk in genome-wide association studies.
A noncoding variant modulating the senescence pathway at chromosome 9p21 linked to differential survival rates into extreme age (>90 years).